Early morning akinesia in Parkinson's disease: Effect of standard carbidopa/levodopa and sustained-release carbidopa/levodopa

Neurology ◽  
1996 ◽  
Vol 46 (4) ◽  
pp. 1059-1062 ◽  
Author(s):  
R. Pahwa ◽  
K. Lyons ◽  
D. McGuire ◽  
R. Dubinsky ◽  
J. P. Hubble ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Sustained Release ◽  
Early Morning ◽  
Disease Effect

scholarly journals Exploratory pilot study of exogenous sustained‐release Melatonin on nocturia in Parkinson’s Disease

2021 ◽  
Author(s):  
Amit Batla ◽  
Sara Simeoni ◽  
Tomoyuki Uchiyama ◽  
Lorenzo deMin ◽  
Joanne Baldwin ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Pilot Study ◽  
Sustained Release

Risk Factors for Dementia in Parkinson's Disease: Effect of Education

1995 ◽  
Vol 15 (1) ◽  
pp. 20-25 ◽  
Author(s):  
S.L. Glatt ◽  
J.P. Hubble ◽  
K. Lyons ◽  
A. Paolo ◽  
A.I. Tröster ◽  
...  
Keyword(s):  
Risk Factors ◽  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Disease Effect

scholarly journals PT320, Sustained-Release Exendin-4, Mitigates L-DOPA-Induced Dyskinesia in a Rat 6-Hydroxydopamine Model of Parkinson’s Disease

2020 ◽  
Vol 14 ◽  
Author(s):  
Seong-Jin Yu ◽  
Shuchun Chen ◽  
Yung-Yung Yang ◽  
Elliot J. Glotfelty ◽  
Jin Jung ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Sustained Release ◽  
6 Hydroxydopamine

scholarly journals Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l -DOPA treatment and changes in levodopa-induced dyskinesia

2017 ◽  
Vol 141 (4) ◽  
pp. 614-625 ◽  
Author(s):  
Andreas Dammann Andersen ◽  
Morten Blaabjerg ◽  
Michael Binzer ◽  
Akram Kamal ◽  
Helle Thagesen ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Cerebrospinal Fluid ◽  
Cerebrospinal Fluid Levels ◽  
Disease Effect ◽  
Fluid Levels
Sign in / Sign up

Export Citation Format

Share Document